Side-by-Side Comparison
| Metric | Cornerstone Pharmaceuticals | PrognosDx Health |
|---|---|---|
| Founded | 2001 | 2008 |
| Headquarters | Cranbury, United States | Palo Alto, United States |
| Employees | 11 | 2-10 |
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care, Medical Devices |
| Funding Stage | Not tracked yet | Debt Financing |
| Total Funding | Not tracked yet | $10.00K |
| Funding Rounds | Not tracked yet | 1 |
| Business Model | Not tracked yet | Not tracked yet |
| Revenue Model | Not tracked yet | Not tracked yet |
| Services | Not tracked yet | Not tracked yet |
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | Metabolic Oncology, Therapeutics, Cancer Treatment, Drug Development, Clinical-stage Company, Bio-energetic Processes, Altered Cancer Metabolism, Novel Drugs, Drug Delivery Technologies, Anti-cancer Agents, Clinical Studies, Mitochondria Targeting, Rare Cancers, Devimistat, Mitochondrial Disruption | Epigenetics, Cancer Diagnostics, Histone Biomarkers, Prostate Cancer, Pharmaceutical Research, Clinical Sample Analysis, Cancer Prognostic Assays, Therapeutic Response Prediction, Research Tools, Palo Alto, Tissue-based Global Cellular Histone Biomarkers |
| Website | cornerstonepharma.com | prognosdx.com |
About Cornerstone Pharmaceuticals
Cornerstone Pharmaceuticals is a clinical-stage biotechnology startup that focuses on developing metabolic oncology therapeutics for hard-to-treat cancers. The company's slogan "Rare Science. Rare Compassion. Rare Solutions." emphasizes its dedication to addressing the unique needs of patients with...
About PrognosDx Health
PrognosDx Health is a biotechnology company that is pioneering the future of cancer diagnostics through advanced epigenetic testing and innovative histone biomarkers. Specializing in developing and commercializing epigenetic tests focusing on histone modification patterns, the company offers service...
Frequently Asked Questions
Track both companies in real time
Signal Tracker monitors Cornerstone Pharmaceuticals, PrognosDx Health, and millions of companies for 40+ signal types.